A. Shin

发表

T Cells Modified with CD70 as an Alternative Cellular Vaccine for Antitumor Immunity

Hyun-Il Cho, Hyun‐Jung Sohn, Tai-Gyu Kim, 2020, Cancer research and treatment : official journal of Korean Cancer Association.

Prime hAd5 Spike + Nucleocapsid Vaccination Induces Ten-Fold Increases in Mean T-Cell Responses in Phase 1 Subjects that are Sustained Against Spike Variants

A. Rice, S. Rabizadeh, P. Soon-Shiong, 2021 .

A recombinant ‘ACE2 Triple Decoy’ that traps and neutralizes SARS-CoV-2 shows enhanced affinity for highly transmissible SARS-CoV-2 variants

Shiho Tanaka, S. Rabizadeh, P. Soon-Shiong, 2021, bioRxiv.

A novel Epstein–Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy

Hyunjoo Lee, Hyun-Il Cho, Tai-Gyu Kim, 2018, British Journal of Cancer.

Complete Protection of Nasal and Lung Airways Against SARS-CoV-2 Challenge by Antibody Plus Th1 Dominant N- and S-Specific T-Cell Responses to Subcutaneous Prime and Thermally-Stable Oral Boost Bivalent hAd5 Vaccination in an NHP Study

J. Safrit, A. Rice, S. Rabizadeh, 2020, bioRxiv.

The miR-24-3p/p130Cas: a novel axis regulating the migration and invasion of cancer cells

J. Rho, W. Song, E. K. Lee, 2016, Scientific Reports.

Th1 Dominant Nucleocapsid and Spike Antigen-Specific CD4+ and CD8+ Memory T Cell Recall Induced by hAd5 S-Fusion + N-ETSD Infection of Autologous Dendritic Cells from Patients Previously Infected with SARS-CoV-2

J. Safrit, A. Rice, S. Rabizadeh, 2020, medRxiv.

An effective peptide vaccine strategy circumventing clonal MHC heterogeneity of murine myeloid leukaemia

Hyun-Il Cho, Tai-Gyu Kim, Sang-Eun Lee, 2020, British Journal of Cancer.

Co-expression of CD40L with CD70 or OX40L increases B-cell viability and antitumor efficacy

Hyun-Il Cho, Tai-Gyu Kim, A. Shin, 2016, Oncotarget.

An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants

Shiho Tanaka, S. Rabizadeh, P. Soon-Shiong, 2021, Scientific Reports.

Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge

J. Safrit, A. Rice, S. Rabizadeh, 2021, Frontiers in Immunology.

A Next Generation Bivalent Human Ad5 COVID-19 Vaccine Delivering Both Spike and Nucleocapsid Antigens Elicits Th1 Dominant CD4+, CD8+ T-cell and Neutralizing Antibody Responses

J. Safrit, Shiho Tanaka, A. Rice, 2020, bioRxiv.

Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice

J. Safrit, Shiho Tanaka, A. Rice, 2021, Scientific Reports.

Single Prime hAd5 Spike (S) + Nucleocapsid (N) Dual Antigen Vaccination of Healthy Volunteers Induces a Ten-Fold Increase in Mean S- and N- T-Cell Responses Equivalent to T-Cell Responses from Patients Previously Infected with SARS-CoV-2

A. Rice, S. Rabizadeh, P. Soon-Shiong, 2021, medRxiv.

The Dual-Antigen Ad5 COVID-19 Vaccine Delivered as an Intranasal Plus Subcutaneous Prime Elicits Th1 Dominant T-Cell and Humoral Responses in CD-1 Mice

J. Safrit, Shiho Tanaka, A. Rice, 2021, bioRxiv.